Session Details
[K1]Kick-off Meeting for the MCM Program 1
Wed. Jul 8, 2026 1:40 PM - 2:29 PM JST
Wed. Jul 8, 2026 4:40 AM - 5:29 AM UTC
Wed. Jul 8, 2026 4:40 AM - 5:29 AM UTC
Ito Hall( Ito International Research Center B2)
Chair:Mizuki Yamamoto, Hotaka Kobayashi
[K1-01]Challenges and Solutions in Promoting Drug Discovery in Academia
*Tatsuya Zenkoh1 (1. The UTOPIA Center, The University of Tokyo (Japan))
[K1-02]Human B cell responses in vaccination and autoimmune disease
*Takeshi Inoue1 (1. The UTOPIA Center, The University of Tokyo (Japan))
[K1-03]Messenger RNA-based Fc-free antibody therapy against Pseudomonas aeruginosa
*Satoshi Uchida1 (1. Department of Advanced Nanomedical Engineering, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo (Japan))
[K1-04]Development of SARS-CoV-2 entry inhibitors
*Mizuki Yamamoto1, Yoko Hirayama1, Jun-ichiro Inoue2, Yasushi Kawaguchi3,1,2, Xuenan Xuan1 (1. Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo (Japan), 2. The University of Tokyo Pandemic preparedness, Infection and Advanced research center (UTOPIA), The University of Tokyo (Japan), 3. Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (Japan))
[K1-05]A platform to monitor mRNA vaccine function with single-molecule imaging
*Hotaka Kobayashi1,2 (1. IQB, The University of Tokyo (Japan), 2. IAMS, Tokushima University (Japan))
[K1-06]Paramyxovirus-Based Platforms for Henipavirus Vaccine Development
*YUYING WANG1, Taishi Onodera2, Yuki Kitai1, Yukiko Akahori1, Hekai Yang1, Hiroshi Katoh1, Akihide Ryo2, Katsumi Maenaka3, Takao Hashiguchi4, Junki Maruyama5, Yoshimasa Takahashi2, Makoto Takeda1 (1. The University of Tokyo (Japan), 2. Japan Institute for Health Security, National Institute of Infectious Diseases (Japan), 3. Hokkaido University (Japan), 4. Kyoto University (Japan), 5. University of Texas Medical Branch (USA))
[K1-07]Engineered virus producer cell-based high throughput screening system
*Kio Horinaka1, Osamu Nureki1, Feng Zhang2 (1. Department of Biological Science, Faculty of Science, The University of Tokyo (Japan), 2. Broad Institute of MIT and Harvard (USA))
